Is Timolol + Travoprost registered with the SFDA?

The SFDA human drug list (edition 4-2026, as published by the Council of Health Insurance) lists 1 valid registration of Timolol + Travoprost, including DUOTRAV EYE DROPS (40,6.8 µg HA/ml,mg/ml, Eye drops, SAR 52.85).

Is Timolol + Travoprost authorised in the European Union?

EMA lists 1 centrally authorised medicine containing Timolol + Travoprost: DuoTrav.

Active substances

Timolol + Travoprost

SFDA 1
EMA 1
Health Canada 2
NHS prices 1

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade name	Strength	Form · route	Pack	Public price	Type	Company	Status
DUOTRAV EYE DROPS	40,6.8 µg HA/ml,mg/ml	Eye drops · Ocular use	1 Dropper Container	SAR 52.85	Generic · Prescription	NOVARTIS PHARMA AG	Valid

Indications — CHI Daman Drug Formulary

OPEN ANGLE GLUCOMA

EMA European Union — centrally authorised medicines

DuoTrav Novartis Europharm Limited · Authorised · authorised 23 Apr 2006 · ATC S01ED51

Therapeutic indication (EMA)

Decrease of intraocular pressure (IOP) in adult patients with open-angle glaucoma or ocular hypertension who are insufficiently responsive to topical beta-blockers or prostaglandin analogues.

Canada Canada — marketed products (Health Canada)

Brand	DIN	Strength	Form · route	Company
APO-TRAVOPROST-TIMOP PQ	02415305	0.004 % / W/V; 0.5 % / W/V	SOLUTION · OPHTHALMIC	APOTEX INC
DUOTRAV PQ	02278251	0.5 % / W/V; 0.004 % / W/V	SOLUTION · OPHTHALMIC	NOVARTIS PHARMACEUTICALS CANADA INC

Prices — United States and England

Source	Product as listed	Price	Unit / pack	Date
NHS Drug Tariff	Travoprost 40micrograms/ml / Timolol 5mg/ml eye drops	£8.45	2.5 ml	1 Oct 2026

NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.

Components

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.